Lac-hydrin and Pulmonary embolism - a phase IV clinical study of FDA data

Summary:

Pulmonary embolism is reported as a side effect among people who take Lac-hydrin (ammonium lactate), especially for people who are female, 50-59 old, also take Protonix, and have Metastases to bone.

The phase IV clinical study analyzes which people have Pulmonary embolism when taking Lac-hydrin. It is created by eHealthMe based on reports of 531 people who have side effects when taking Lac-hydrin from the FDA, and is updated regularly.

What is Lac-hydrin?

Lac-hydrin has active ingredients of ammonium lactate. eHealthMe is studying from 534 Lac-hydrin users. Check the latest studies of Lac-hydrin.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,345 drugs and 2,950 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

On May, 18, 2026

531 people reported to have side effects when taking Lac-hydrin.
Among them, 25 people (4.71%) have Pulmonary embolism.

Could Lac-hydrin cause Pulmonary embolism?

Among these 25 people:

What is the gender of people who have Pulmonary embolism when taking Lac-hydrin? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Lac-hydrin and have Pulmonary embolism?

- Check whether Pulmonary embolism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lac-hydrin:

Lac-hydrin (534 reports)

Pulmonary embolism treatments and more:

Pulmonary embolism (160,405 reports)

How severe was Pulmonary embolism and when was it recovered:

Pulmonary embolism in Lac-hydrin

Expand to all the drugs that have ingredients of ammonium lactate:

Pulmonary embolism and drugs with ingredients of ammonium lactate (37 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lac-hydrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary embolism:

Pulmonary embolism (2,345 drugs)

Browse all the conditions that are associated with Pulmonary embolism:

Pulmonary embolism (2,950 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ammonium lactate (the active ingredients of Lac-hydrin) and Lac-hydrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.